Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Li Kang Biomedical CoROCO:6242 81 OCF Margin % is 39.18% as of Dec. 2025, which is 112% above its 10-year median of 18.52. GuruFocus rates ROCO:6242 with a GF Score™ of 81/100 and a GF Value™ of NT$38.97 (Fairly Valued). The stock has 3 warning signs investors should review. Among 841 Travel & Leisure companies, Li Kang Biomedical Co ranks better than 53.51% on this metric.
The historical rank and industry rank for Li Kang Biomedical Co's OCF Margin % or its related term are showing as below:
ROCO:6242'
s OCF Margin % Range Over the Past 10 Years
Min: 11.56 Med: 18.52 Max: 24.59
Current: 15.64
During the past 13 years, the highest OCF Margin % of Li Kang Biomedical Co was 24.59%. The lowest was 11.56%. And the median was 18.52%.
ROCO:6242's OCF Margin % is ranked better than 53.51% of 841
companies
in the Travel & Leisure industry
Industry Median: 14.02
vs ROCO:6242: 15.64
Li Kang Biomedical Co OCF Margin % Related Terms
Li Kang Biomedical Co OCF Margin % Historical Data
* Premium members only.
The historical data trend for Li Kang Biomedical Co's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6242 vs BKNG, ABNB, RCL: OCF Margin % Comparison
For the Travel Services subindustry, Li Kang Biomedical Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Li Kang Biomedical Co OCF Margin % vs Travel & Leisure Industry
For the Travel & Leisure industry and Consumer Cyclical sector, Li Kang Biomedical Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Li Kang Biomedical Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Li Kang Biomedical Co (ROCO:6242) has a OCF Margin % of 39.18% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Li Kang Biomedical Co and its competitors. This is 112% above median its historical median of 18.52. Over the past decade, Li Kang Biomedical Co's OCF Margin % has ranged from 11.56 to 24.59. According to the industry distribution chart, Li Kang Biomedical Co ranks #391 out of 841 companies in the Travel & Leisure industry, placing it in the top 46.5%.
Is Li Kang Biomedical Co's OCF Margin % too high?
Li Kang Biomedical Co's current OCF Margin % of 39.18% is 112% above median its 10-year median of 18.52. Over the past 10 years, this metric has ranged from a low of 11.56 to a high of 24.59. The Travel & Leisure industry median OCF Margin % is 14.02. Li Kang Biomedical Co's value of 39.18% is 179.5% above this industry median. Based on the distribution chart, Li Kang Biomedical Co ranks #391 out of 841 companies in the Travel & Leisure industry, which is above the industry midpoint. Overall, Li Kang Biomedical Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Li Kang Biomedical Co's OCF Margin % compare to BKNG and ABNB?
According to the Travel & Leisure industry distribution chart, Li Kang Biomedical Co ranks #391 out of 841 companies for OCF Margin %. This puts Li Kang Biomedical Co in the upper half of its industry. The industry median OCF Margin % is 14.02. Li Kang Biomedical Co's value of 39.18% is 179.5% above this benchmark. Historically, Li Kang Biomedical Co's own OCF Margin % has ranged from 11.56 to 24.59 over the past decade. While the company's 10-year median is 18.52 vs. the industry median of 14.02, Li Kang Biomedical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Travel & Leisure company?
The median OCF Margin % among Travel & Leisure companies is 14.02, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Li Kang Biomedical Co's current OCF Margin % of 39.18% is 179.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Li Kang Biomedical Co and its competitors. For the Travel & Leisure industry, the median OCF Margin % is 14.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Li Kang Biomedical Co's current OCF Margin % is 39.18%, which is 112% above median its own 10-year median of 18.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Li Kang Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Li Kang Biomedical Co (ROCO:6242) is currently considered Fairly Valued. The stock's GF Value™ is NT$38.97, compared to a current price of NT$35.95 — trading 7.7% below its estimated fair value. The current OCF Margin % is 39.18%, which is 112% above median its 10-year median of 18.52 and 179.5% above the Travel & Leisure industry median of 14.02. Li Kang Biomedical Co's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Li Kang Biomedical Co (ROCO:6242), the current OCF Margin % is 39.18% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Li Kang Biomedical Co (ROCO:6242) Overvalued in 2026?
Based on GuruFocus' analysis, Li Kang Biomedical Co stock appears to be undervalued.
The current stock price of NT$35.95 is trading 7.7% below its estimated GF Value™ of NT$38.97.
GuruFocus considers Li Kang Biomedical Co to be Fairly Valued.
Key valuation signals for ROCO:6242:
OCF Margin %: 39.18% (112% above median its 10-year median of 18.52)
GF Value™: NT$38.97 vs. price of NT$35.95 (7.7% below fair value)
Industry Position: 179.5% above the Travel & Leisure median (#391 of 841)
No single metric tells the full story. See the ROCO:6242 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Li Kang Biomedical Co Ltd is a Taiwan based company engages in tourism factory businesses, telemarketing, as well as the manufacturing and sales of cosmetics and hygienic drinks.
81GF Score
Get the complete analysis for ROCO:6242
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6242 has been successfully added to your 
